Clinical TrialsSearch results
Number of results: 266
Recruiting
- Abelacimab versus apixaban in the treatment of cancer associated VTE
- Cancer associatated thrombosis
- Hara Yochiro
- 2023-08-29
Recruiting
- A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER+/HER2- Early Breast Cancer
- Breast Cancer, Early Breast Cancer
- Hibi Kazushige
- 2023-05-26
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- Phase 2 study of cisplatin and pemetrexed in previously treated patients with malignant pleural mesothelioma
- Malignant pleural mesothelioma
- Hyogo College of Medicine
- 2008-01-04
Other
- Aichi - Research on Combination therapy in Hypertension (ARCH): Multi-center observational study on hypertensive's actual condition and effectiveness of the patient preference on an ARB and diuretic combination therapy in hypertensive patients who are under drug treatment
- Hypertension
- Hypertension Academy in NAGOYA
- 2007-09-03
Recruiting
- Accuracy of quantification of myocardial blood flow by Dynamic Stress Perfusion CT: verification with 15O-H2O PET
- Known or suspected chronic coronary artery disease
- Ichikawa Yasutaka
- 2022-07-15
Not yet recruiting
- Safety and efficacy evaluation of laparoscopic abdominal cerclage in patients with cervical insufficiency
- cervical insufficiency
- Ikeda Tomoaki
- 2021-09-13
Other
- A study to test whether different doses of BI 1291583 help people with bronchiectasis
- non-cystic fibrosis bronchiectasis (nCFB)
- Imazu Susumu
- 2022-10-18
Recruiting
- The effect of PDE5 inhibitor on human sperm (PEOS study)
- oligospermia, Asthesospermia, sperm shape abnormality, white blood cells in sperm
- Inoue Takahiro
- 2022-01-27
Recruiting
- Multi-institutional phase 1 clinical study to examine the safety and tolerability of MU-MA402C for MAGE A4-positive and HLA-A*02:01-positive unresectable advanced or recurrent solid cancer
- MAGE A4-positive and HLA-A*02:01-positive unresectable advanced or recurrent solid cancer
- Ishihara Mikiya
- 2021-10-05